Relationship among Parkinson’s disease, constipation, microbes, and microbiological therapy

5Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This comprehensive review elucidates the complex interplay between gut microbiota and constipation in Parkinson’s disease (PD), a prevalent non-motor symptom contributing significantly to patients’ morbidity. A marked alteration in the gut microbiota, predominantly an increase in the abundance of Proteobacteria and Bacteroidetes, is observed in PD-related constipation. Conventional treatments, although safe, have failed to effectively alleviate symptoms, thereby necessitating the development of novel therapeutic strategies. Microbiological interventions such as prebiotics, probiotics, and fecal microbiota transplantation (FMT) hold therapeutic potential. While prebiotics improve bowel movements, probiotics are effective in enhancing stool consistency and alleviating abdominal discomfort. FMT shows potential for significantly alleviating constipation symptoms by restoring gut microbiota balance in patients with PD. Despite promising developments, the causal relationship between changes in gut microbiota and PDrelated constipation remains elusive, highlighting the need for further research in this expanding field.

Cite

CITATION STYLE

APA

Yuan, X. Y., Chen, Y. S., & Liu, Z. (2024). Relationship among Parkinson’s disease, constipation, microbes, and microbiological therapy. World Journal of Gastroenterology. Baishideng Publishing Group Inc. https://doi.org/10.3748/wjg.v30.i3.225

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free